Valneva SE's (EPA:VLA) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Apr 05
French (CAC) Biotech Industry Analysis
UpdatedApr 22, 2024
DataAggregated Company Financials
Companies27
- 7D-1.4%
- 3M4.8%
- 1Y-13.0%
- YTD0.9%
Over the last 7 days, the Biotech industry has dropped 1.4%, driven by a pullback from Valneva of 7.6%. Meanwhile, OSE Immunotherapeutics actually outperformed within the industry, gaining 29% in the last week. Overall the industry is down 13% in 12 months. Earnings are forecast to grow by 28% annually.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 23 Apr 2024 | €3.2b | €515.6m | -€629,088,205.81 | 27.2x | -5.1x | 6.2x |
| Thu, 21 Mar 2024 | €3.1b | €567.7m | -€645,511,764.51 | 22.2x | -4.8x | 5.5x |
| Sat, 17 Feb 2024 | €3.1b | €558.9m | -€674,906,399.20 | 22.6x | -4.6x | 5.5x |
| Mon, 15 Jan 2024 | €3.1b | €594.2m | -€683,192,676.00 | 23.6x | -4.5x | 5.2x |
| Wed, 13 Dec 2023 | €3.1b | €594.7m | -€685,615,333.00 | 22.1x | -4.6x | 5.3x |
| Fri, 10 Nov 2023 | €3.4b | €803.2m | -€579,099,399.00 | 21.8x | -5.9x | 4.2x |
| Sun, 08 Oct 2023 | €3.2b | €831.2m | -€598,731,137.00 | 14.1x | -5.3x | 3.8x |
| Tue, 05 Sep 2023 | €3.9b | €818.3m | -€727,538,072.00 | 24.3x | -5.4x | 4.8x |
| Thu, 03 Aug 2023 | €3.6b | €818.5m | -€737,639,796.00 | 24.5x | -4.9x | 4.5x |
| Sat, 01 Jul 2023 | €3.7b | €819.8m | -€743,700,189.00 | 25.1x | -5x | 4.5x |
| Mon, 29 May 2023 | €3.7b | €825.3m | -€771,979,026.00 | 25.8x | -4.8x | 4.5x |
| Wed, 26 Apr 2023 | €3.5b | €882.6m | -€809,759,980.00 | 28.9x | -4.3x | 4x |
| Fri, 24 Mar 2023 | €3.3b | €1.0b | -€477,726,483.00 | 9x | -6.8x | 3.2x |
| Sun, 19 Feb 2023 | €3.6b | €1.0b | -€457,031,731.00 | 10.9x | -7.9x | 3.5x |
| Tue, 17 Jan 2023 | €3.9b | €1.0b | -€455,905,151.00 | 13.6x | -8.6x | 3.8x |
| Thu, 15 Dec 2022 | €3.5b | €1.0b | -€455,784,247.00 | 12.7x | -7.6x | 3.3x |
| Sat, 12 Nov 2022 | €3.6b | €905.1m | -€699,425,346.00 | 16x | -5.1x | 4x |
| Mon, 10 Oct 2022 | €3.6b | €923.5m | -€706,474,434.00 | 30.6x | -5.1x | 3.9x |
| Wed, 07 Sep 2022 | €4.3b | €930.4m | -€753,215,349.00 | 109.4x | -5.7x | 4.6x |
| Fri, 05 Aug 2022 | €4.4b | €985.2m | -€681,068,518.00 | 122.5x | -6.5x | 4.5x |
| Sun, 03 Jul 2022 | €4.3b | €985.7m | -€682,276,154.00 | 124.1x | -6.3x | 4.4x |
| Tue, 31 May 2022 | €4.8b | €989.6m | -€687,844,879.00 | 135.3x | -7x | 4.9x |
| Thu, 28 Apr 2022 | €4.5b | €1.2b | -€498,925,337.00 | 2.8x | -9x | 3.7x |
| Sat, 26 Mar 2022 | €5.3b | €928.0m | -€612,906,673.00 | 17.6x | -8.6x | 5.7x |
| Mon, 21 Feb 2022 | €5.3b | €941.0m | -€673,068,392.00 | 18.3x | -7.8x | 5.6x |
| Wed, 19 Jan 2022 | €5.9b | €931.8m | -€678,498,836.00 | 3.1x | -8.6x | 6.3x |
| Fri, 17 Dec 2021 | €7.3b | €926.0m | -€680,690,819.00 | 3.1x | -10.7x | 7.8x |
| Sun, 14 Nov 2021 | €6.8b | €924.9m | -€696,829,262.00 | 2.2x | -9.8x | 7.4x |
| Tue, 12 Oct 2021 | €6.0b | €891.7m | -€679,149,543.00 | 2.8x | -8.9x | 6.8x |
| Thu, 09 Sep 2021 | €8.0b | €878.8m | -€620,422,159.12 | 2.8x | -13x | 9.1x |
| Sat, 07 Aug 2021 | €6.4b | €899.6m | -€600,532,159.12 | 2.6x | -10.6x | 7.1x |
| Fri, 30 Apr 2021 | €7.2b | €882.0m | -€570,006,611.92 | 3.1x | -12.7x | 8.2x |
Price to Earnings Ratio
-12.7x
Current Industry PE
- Investors are optimistic on the French Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 5.3x is lower than the industry's current PS ratio of 6.2x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 16% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | -0.12% | |
| Healthcare | -2.60% | |
| Biotech | -1.42% | |
| Biotech | -1.42% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| OSE OSE Immunotherapeutics | €5.97 | 29.4% +€29.2m | 37.4% | PS57.8x | |
| ABVX ABIVAX Société Anonyme | €14.40 | 3.0% +€26.4m | -7.8% | PS201.7x | |
| ALNOV Novacyt | €0.78 | 18.0% +€8.4m | 38.1% | PS6x | |
| ALCLS Cellectis | €2.46 | 3.6% +€6.1m | 37.0% | PS7.7x | |
| POXEL Poxel | €0.79 | 21.3% +€5.4m | 15.0% | PS19.8x |